Mel King (she/her), PharmD, RPh

THANK YOU @ HOCKEY GODS!!

COBRRA trial: Apixaban vs rivaroxaban in acute VTE Less Bleeding (>50%) Comparable Recurrent VTE Early divergence in risk Practice-changing insights with Dr. Lana Castellucci Listen now at buzzsprout.com/1946680/episod… or on your preferred podcast platform. #VTE #Thrombosis

Attention students! We have an upcoming Symposium where you can network with hospital pharmacists and learn about their roles in hospital. Be sure to sign up in the school Facebook group - lunch will be provided! #PAM2026 @schoolofpharm pic.twitter.com/laI71GZyBE

Today is International Day of Women & Girls in Science! Highlighting the women who work at BC Cancer Pharmacy, practically contributing with STEM skills to the care of cancer patients! #WomenInScience

Are you getting questions from patients about acetaminophen? We've developed a new FAQ resource to help you address patient concerns about acetaminophen use in pregnancy with clear, evidence-based information. 👉 Access the FAQ here: ow.ly/GKfr50X2ti1

As World Pharmacist Day draws to an end shout to all our amazing #BOPA members for all the work they do to support our mission to maximise the potential of the cancer Pharmacy team to optimise the care of people living with cancer #WPD2025 #WorldPharmacistDay #ThinkPharmacist

@WolverHeme @Berninini @ajperissinotti Awesome episode!

We're BACK after a summer break! Listen to our latest episode "Prophy and Pints"! Let us de-mystify antimicrobial prophylaxis and help you choose the best regimen for your patients! 🦠💊 @Berninini @ajperissinotti open.spotify.com/episode/20OItl…

Applications for the 2026 Common Sense Oncology Cancer Health Services Research Fellowship will close on Sept 18, 2025, at 4 pm EDT. If you are approaching completion of training in clinical or medical oncology, or have completed training within the last five years, this opportunity is for you! For more fellowship details, view the posting online: tinyurl.com/37cdc5sy #CommonSenseOncology #CancerCare

CSHP and @CAPSInational were thrilled to present Melanie King with the 2024 – 2025 Hospital Pharmacy Student Award back in January at PDW! Melanie’s dedication to excellence, mentorship, and patient care sets a strong foundation for a remarkable pharmacy career ahead.

Liz hopes that sharing her cervical cancer survival story will inspire and empower Canadians to take preventative action against #HPV (a virus that causes cervical cancer). #DontLetHistoryRepeatItself #GetImmunized #VaccinesWork #NIAW2025

New study, new standard? Reduced-dose apixaban may change the game in cancer-associated thrombosis. Dr. Carrier explains why. 🎙️ Listen: thrombosiscanada.ca/hcp/clot-conve… #CLOTConversations #VTE #Apixaban

On this #WorldCancerDay , we are delighted to announce Common Sense Oncology checklist for improving the design and reporting of cancer drug RCTs, published in @TheLancetOncol. Implementation of this checklist will help ensure that cancer drug RCTs are designed to answer questions that matter to patients and are interpreted correctly. thelancet.com/journals/lanon…

@LynneNakashima Enjoy, I loved Portugal!

Views of Cascais, Portugal!

We would like to extend a huge congratulations to a student member, Melanie King, for being awarded the CSHP/CAPSI Hospital Pharmacy Student Award for the country for 2024-25! What an incredible accomplishment. @schoolofpharm @capsinational @capsimun

@WolverHeme @ajperissinotti @Berninini @LymphClinician Great Christmas gift😊🎄

Just in time for the holidays! 🥂🎄 "Pour Decisions, or ASH-olutely Fabulous? Reviewing 2024 ASH Lymphoma Updates" #lymsm @ajperissinotti @Berninini @LymphClinician creators.spotify.com/pod/show/wolve…

Pharmacists can and should be playing a greater role in primary health care delivery. cbc.ca/news/health/ci… @HCS_GovNL @PremierofNL

Check out our latest ASH 2024 episode! "A Bunch of ASHholes Discuss Myeloma Abstracts" You won't want to miss this spicy 🔥myeloma discussion! @ajperissinotti @Berninini @ManniMD1 @AaronGoodman33 creators.spotify.com/pod/show/wolve…

23 years ago, the FDA approved a drug that changed the life of millions of patients with chronic myeloid leukemia 💪🏼 Thank you Dr. Druker 🙏🏼 Thank you imatinib 🙏🏼 #MedTwitter

Our newest episode is out🗳️"Cast your vote! Nivolumab vs. Brentuximab for Classical Hodgkin Lymphoma" Listen to @dgermain21 @LymphClinician @Berninini @ajperissinotti debate the optimal treatment of upfront cHL #lymphsm #twitterx podcasters.spotify.com/pod/show/wolve…